Purpose By incorporating major developments in genetics, ophthalmology, dermatology,
and neuroimaging, to revise the diagnostic criteria for neurofibromatosis type 1 (NF1) and to …

NEUROFIBROMATOSIS 2 (NF2) is an autosomal dominant disease predisposing to multiple
tumors of the central and peripheral nervous system. Bilateral vestibular schwannomas are …

Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder leading to various
tumors of the CNS, with vestibular schwannomas being the hallmark of the disease. We have …

The most frequent recurring mutations in neurofibromatosis type 1 (NF1) are large deletions
encompassing the NF1 gene and its flanking regions (NF1 microdeletions). The majority of …

Purpose Neurofibromatosis type 2 (NF2) and schwannomatosis (SWN) are genetically distinct
tumor predisposition syndromes with overlapping phenotypes. We sought to update the …

The vast majority of peripheral nerve sheath tumors derive from the Schwann cell lineage
and comprise diverse histological entities ranging from benign schwannomas and …

Background Large deletions of the NF1 gene region occur in ∼5% of patients with
neurofibromatosis type-1 (NF1) and are associated with particularly severe manifestations of the …

Bilateral vestibular schwannomas are the hallmark of neurofibromatosis type 2 (NF2), and
these tumors impair hearing and frequently lead to deafness. Neurosurgical intervention, the …

Neurofibromatosis 1 (NF1) is one of the most common autosomal dominant diseases. Although
there is a considerable variability in clinical expression, NF1 is almost fully penetrant in …

OBJECTIVES: To define the frequency and clinical features of plexiform neurofibromas (PN)
in children with neurofibromatosis type 1. STUDY DESIGN: Sixty-five children received …